Cristina Cadenas

Dr. Cristina Cadenas


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2017 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
MLMarcel Leist
Marcel Leist
AGAhmed Ghallab
Ahmed Ghallab
RGRabea Graepel
Rabea Graepel
RMRosemarie Marchan
Rosemarie Marchan
RHReham Hassan
Reham Hassan
Jan G HengstlerJan G Hengstler
Jan G Hengstler

15 October 2014 in Cell Cycle
Verified
Journal Article
Open access
CCCristina Cadenas
Cristina Cadenas
LSLeonie van de Sandt
Leonie van de Sandt
KEKarolina Edlund
Karolina Edlund
MLMiriam Lohr
Miriam Lohr
BHBirte Hellwig
Birte Hellwig
Jan G HengstlerJan G Hengstler
Jan G Hengstler
Several studies suggest a link between circadian rhythm disturbances and tumorigenesis. However, the association between circadian clock genes and prognosis in breast cancer has not been systematically studied. Therefore, we examined the expression of 17 clock components in tumors from 766 node-negative breast cancer patients that were untreated in both neoadjuvant and adjuvant settings. In addition, their association with metastasis-free survival (MFS) and correlation to clinicopathological parameters were investigated. Aiming to estimate functionality of the clockwork, we studied clock gene expression relationships by correlation analysis. Higher expression of several clock genes (e.g., CLOCK, PER1, PER2, PER3, CRY2, NPAS2 and RORC) was found to be associated with longer MFS in univariate Cox regression analyses (HR<1 and FDR-adjusted P < 0.05). Stratification according to molecular subtype revealed prognostic relevance for PER1, PER3, CRY2 and NFIL3 in the ER+/HER2- subgroup, CLOCK and NPAS2 in the ER-...

1 September 2012 in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Verified
Journal Article
Closed access
CCCristina Cadenas
Cristina Cadenas
SVSonja Vosbeck
Sonja Vosbeck
EHEva-Maria Hein
Eva-Maria Hein
BHBirte Hellwig
Birte Hellwig
ALAlice Langer
Alice Langer
Jan G HengstlerJan G Hengstler
Jan G Hengstler

28 September 2018 in Genome Biology
Verified
Journal Article
Open access
PDF file
ASAbdulrahman Salhab
Abdulrahman Salhab
KNKarl Nordström
Karl Nordström
GGGilles Gasparoni
Gilles Gasparoni
Kathrin KattlerKathrin Kattler
Kathrin Kattler
PEPeter Ebert
Peter Ebert
JWJörn Walter
Jörn Walter
Partially methylated domains are extended regions in the genome exhibiting a reduced average DNA methylation level. They cover gene-poor and transcriptionally inactive regions and tend to be heterochromatic. We present a comprehensive comparative analysis of partially methylated domains in human and mouse cells, to identify structural and functional features associated with them. Partially methylated domains are present in up to 75% of the genome in human and mouse cells irrespective of their tissue or cell origin. Each cell type has a distinct set of partially methylated domains, and genes expressed in such domains show a strong cell type effect. The methylation level varies between cell types with a more pronounced effect in differentiating and replicating cells. The lowest level of methylation is observed in highly proliferating and immortal cancer cell lines. A decrease of DNA methylation within partially methylated domains tends to be linked to an increase in heterochromatic histone marks and a decrease of gene expression. Characteristic combinations of heterochromatic signatures in partially methylated domains are linked to domains of early and middle S-phase and late S-G2 phases of DNA replication. Partially methylated domains are prominent signatures of long-range epigenomic organization. Integrative analysis identifies them as important general, lineage- and cell type-specific topological features. Changes in partially methylated domains are hallmarks of cell differentiation, with decreased methylation levels and increased heterochromatic marks being linked to enhanced cell proliferation. In combination with broad histone marks, partially methylated domains demarcate distinct domains of late DNA replication.

16 November 2018 in Liver International
Verified
Journal Article
Closed access
PDF file
CHChristian A. Hudert
Christian A. Hudert
SSSilvia Selinski
Silvia Selinski
BRBirgit Rudolph
Birgit Rudolph
HBHendrik Bläker
Hendrik Bläker
CLChristoph Loddenkemper
Christoph Loddenkemper
SWSusanna Wiegand
Susanna Wiegand

1 August 2021 in Cell Reports
Verified
Journal Article
Open access
KGKathrin Gianmoena
Kathrin Gianmoena
NGNina Gasparoni
Nina Gasparoni
AJAdelina Jashari
Adelina Jashari
PGPhilipp Gabrys
Philipp Gabrys
KGKatharina Grgas
Katharina Grgas
CCCristina Cadenas
Cristina Cadenas
Epigenetic modifications (e.g. DNA methylation) in NAFLD and their contribution to disease progression and extrahepatic complications are poorly explored. Here, we use an integrated epigenome and transcriptome analysis of mouse NAFLD hepatocytes and identify alterations in glyoxylate metabolism, a pathway relevant in kidney damage via oxalate release-a harmful waste product and kidney stone-promoting factor. Downregulation and hypermethylation of alanine-glyoxylate aminotransferase (Agxt), which detoxifies glyoxylate, preventing excessive oxalate accumulation, is accompanied by increased oxalate formation after metabolism of the precursor hydroxyproline. Viral-mediated Agxt transfer or inhibiting hydroxyproline catabolism rescues excessive oxalate release. In human steatotic hepatocytes, AGXT is also downregulated and hypermethylated, and in NAFLD adolescents, steatosis severity correlates with urinary oxalate excretion. Thus, this work identifies a reduced capacity of the steatotic liver to detoxify glyoxylate, triggering elevated oxalate, and provides a mechanistic explanation for the increased risk of kidney stones and chronic kidney disease in NAFLD patients.